Wiki Articles - Finance

With the Dow breaking out over the key 12,000 mark the time has come to determine the health of the overall markets. In performing this a

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

nalysis it is important to also evaluate other indices such as the NASDAQ and the S&P 500.

>>> Dow Jones Industrial Average (DJIA) - The

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

Dow Jones has continued to perform well recently which is in line with our prediction that leading large cap firms would lead the charge

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

hroughout the rest of this decade. On a five-year monthly chart you would notice that the Dow has broken out from its consolidation perio

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

and is splitting the upper and lower Bollinger Bands apart. When the Bollinger Bands tighten we are to assume that the index, or stock,

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

s trading within a consolidation range. For the Dow, this range was between 10,000 and 11,000. So, when the pressure was finally released

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

, the Dow Jones broke to the upside. I believe the market is only in the beginning stages of its next powerful move to the upside. The re

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

son for this assumption is due to the fact that the MACD and DMI indicators continue to signal investors to buy. Until one of these two i

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

dicators fails, I would recommend that you take advantage of what the market is telling you.

>>> S&P 500 Index (SP500) - The S&P500 is a

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

leading index, so the question I would ask myself is, “Are the recent highs of the Dow Jones justified?” Again, from looking at a five-ye

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

r monthly chart, the answer is an obvious yes. This index continued to trend north and is supported by a recent breakout from consolidati

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

on. In addition to this, the MACD and DMI also hint that this is a buying opportunity for the long-term.

>>> Nasdaq Composite Index (NAS

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

AQ) - The NASDAQ’s five-year monthly chart tells the same story, but in a slightly different way. In this case only the DMI has signaled

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

uy, while the MACD has yet to turn positive. While the Dow Jones and the S&P500 jump out to an early start, they will not experience the

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

xplosion out from the gate that the NASDAQ will. The NASDAQ is still trading within its range between 2,000 and 2,500. Also, the Bollinge

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

Bands have not split open yet (signaling volatility), but I would not expect that to happen until the NASDAQ surpasses the 2,500 mark. U

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

ntil then, I am pleased to know that the NASDAQ will eventually breakout and with great conviction. This is due to the fact that the long

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

r an index or security trades in a tight range, the more pressure and momentum will be present when the big move finally does occur.

Ove

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

all, two out of the three main indices have begun their next climb and seem to justify each other’s moves. Once the NASDAQ is finally on

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

oard I believe there will be heavy buying across the board, indicating that the late 2000s stock market boom is for real.

Good Investing

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.wiki-articles.org.ua/article/117096/wiki-articles-Stock-Market-Update-October-23-2006.html">Stock Market Update: October 23, 2006</a>

BB link (for phorums):
[url=http://www.wiki-articles.org.ua/article/117096/wiki-articles-Stock-Market-Update-October-23-2006.html]Stock Market Update: October 23, 2006[/url]

When you are looking for freelance writing work, it is important to look outside the box as well as trying the tried and true employment options.

Conventional methods prevent business change for planned and managed benefits and return. R-pM provides the proper method for business change in the 21st century enterprise to leave 20th century change management problems behind.

So you want to incorporate your business or form an LLC. Should you use an attorney, hire one of the hundreds of online incorporation companies, or do it yourself?

Tags

Links

Wiki Articles - Stock Market Update: October 23, 2006

Related Articles: